| Literature DB >> 31745457 |
Martine E Oloume1, Abas Mouliom1, Bernard F Melingui1, Suzanne Belinga2, Julie S Nana3, Mathurin Tejiokem4, Francoise N Sack5, Jeanne Manga6, Annie R Epote1.
Abstract
BACKGROUND: Haematological values derived from local populations are useful in laboratories to improve diagnoses for local patients. In Cameroon, these data are not yet available. Moreover, there is great variation in baseline parameters pertaining to full blood cell count among medical laboratories.Entities:
Keywords: complete blood cell count; locally derived ranges; reticulocyte count
Year: 2019 PMID: 31745457 PMCID: PMC6852616 DOI: 10.4102/ajlm.v8i1.852
Source DB: PubMed Journal: Afr J Lab Med ISSN: 2225-2002
Exclusion criteria applied to the study population in Yaoundé, Cameroon, November 2015 – September 2016.
| Exclusion criteria | Men ( | Women ( | Total ( |
|---|---|---|---|
| HIV | 4 | 1 | 5 |
| Hepatitis B | 17 | 3 | 20 |
| Hepatitis C | 10 | 1 | 11 |
| Syphilis | 8 | 2 | 10 |
| Blood parasites (microfilariae, malaria) | 9 | 6 | 15 |
| C-reactive protein ˃ 6 mg/L | 33 | 11 | 44 |
| Platelet aggregates | 1 | 3 | 4 |
| Smokers ˃ 5 cigarettes/day | 2 | 0 | 2 |
| Population | 222 | 153 | 375 |
| Population after exclusion criteria were applied | 161 | 133 | 294 |
, Many participants met several exclusion criteria at the same time. For example, some donors presented an increased C-reactive protein and a positive serology test or a positive blood parasite test and therefore appear more than once as exclusions.
FIGURE 1Distribution of study participants by age group, Yaoundé, Cameroon, November 2015 – September 2016.
Study population by main ethnic groups, Yaoundé, Cameroon, November 2015 – September 2016.
| Ethnic groups | Frequency | Percentage |
|---|---|---|
| Southern forest peoples | 135 | 45.9 |
| Kirdi | 3 | 1.0 |
| Coastal forest peoples | 39 | 13.3 |
| Western highlanders | 108 | 36.7 |
| Fulas | 9 | 3.1 |
Erythrocyte parameters for men and women, Yaoundé, Cameroon, November 2015 – September 2016.
| Parameter | Men ( | Women ( | |||
|---|---|---|---|---|---|
| Median | 2.5% – 97.5% | Median | 2.5% – 97.5% | ||
| Red blood cells (× 1012/L) | 4.87 | 4.00–5.90 | 4.11 | 3.40–5.30 | < 0.001 |
| Haemoglobin (g/L) | 135.00 | 110.00–160.00 | 114.00 | 98.90–137.00 | < 0.001 |
| Haematocrit (%) | 41.80 | 34.60–47.61 | 35.61 | 29.70–42.00 | < 0.001 |
| MCH (pg) | 28.20 | 22.80–33.40 | 28.10 | 23.22–31.20 | 0.890 |
| MCHC (g/L) | 323.00 | 299.00–353.00 | 321.00 | 300.00–342.00 | 0.054 |
| MCV (fL) | 86.00 | 70.00–97.00 | 87.00 | 72.00–96.00 | 0.470 |
| RDI (%) | 17.00 | 13.40–21.00 | 16.70 | 13.70–20.00 | 0.900 |
| Reticulocytes (× 109/L) | 60.00 | 30.00–250.00 | 40.00 | 20.00–177.00 | < 0.001 |
MCHC, mean corpuscular haemoglobin concentration; MCH, mean haemoglobin concentration; MCV, mean corpuscular volume; RDI, red blood cell distribution index; N, number.
Platelet parameters for men and women, Yaoundé, Cameroon, November 2015 – September 2016.
| Parameter | Men ( | Women ( | |||
|---|---|---|---|---|---|
| Median | 2.5% – 97.5% | Median | 2.5% – 97.5% | ||
| Platelets (× 109/L) | 211.00 | 133.00–339.00 | 243.00 | 143.00–369.00 | < 0.001 |
| MPV (fL) | 9.20 | 7.60–11.00 | 9.30 | 7.40–11.30 | 0.13 |
| THT (%) | 0.19 | 0.13–0.32 | 0.23 | 0.12–0.34 | < 0.001 |
| PDI (%) | 16.10 | 11.90–21.30 | 16.30 | 11.50–21.80 | 0.37 |
MPV, mean platelet volume; THT, thrombocrit; PDI, platelet distribution index; N, number.
White blood cell parameters for men and women, Yaoundé, Cameroon, November 2015 – September 2016.
| Parameter | Men ( | Women ( | |||
|---|---|---|---|---|---|
| Median | 2.5% – 97.5% | Median | 2.5% – 97.5% | ||
| White blood cell (× 109/L) | 4.10 | 2.60–6.81 | 4.60 | 2.80–6.70 | 0.008 |
| Neutrophils (× 109/L) | 1.60 | 0.92–3.00 | 1.98 | 1.01–3.53 | 0.002 |
| Eosinophils (× 109/L) | 0.20 | 0.05–0.98 | 0.15 | 0.12–0.42 | < 0.001 |
| Basophils (× 109/L) | 0.08 | 0.03–0.22 | 0.08 | 0.03–0.29 | 0.48 |
| Lymphocytes (× 109/L) | 1.71 | 1.03–3.13 | 1.89 | 1.06–2.90 | 0.11 |
| Monocytes (× 109/L) | 0.26 | 0.11–0.54 | 0.32 | 0.14–0.65 | 0.003 |
Haematological locally derived ranges from our study compared with sources from other studies.
| Parameters | Our study | Ghana[ | Togo[ | Kenya[ | France[ |
|---|---|---|---|---|---|
| Male | 110.00–160.00 (135.00) | 113.00–164.00 (139.00) | 100.00–184.00 (151) | 114.00–169.00 (14.2) | 134.00–167.00 |
| Female | 98.90–137.00 (114.00) | 88.00–144.00 (123.00) | 103.00–171.00 (130) | 80.00–142.00 (121.0) | 115.00–149.00 |
| Male | 4.00–5.90 (4.87) | 3.79–5.96 (4.84) | 3.30–6.40 (5.0) | 4.30–6.50 (5.3) | 4.53–5.79 |
| Female | 3.40–5.30 (4.11) | 3.09.00–5.30 (4.32) | 3.10–6.00 (4.5) | 3.40–5.70 (4.5) | 4.01–5.19 |
| Male | 34.60–47.61 (41.80) | 33.2–50.5 (42.20) | 28.00–54.00 (42.8) | 32.60–51.50 (41.7) | 39.20–48.60 |
| Female | 29.70–42.00 (35.61) | 26.4–45.0 (36.90) | 28.00–47.00 (38.1) | 23.20–44.30 (35.8) | 34.40–43.90 |
| Male | 22.80–33.40 (28.20) | 22.7–33.5 (29.10) | 26.00–36.00 (29.7) | NA | 27.30–32.80 |
| Female | 23.22–31.20 (28.10) | 22.3–33.6 (28.40) | 25.00–37.00 (29.3) | NA | 24.40–32.10 |
| Male | 299.00–353.00 (323.00) | 306.00–360.00 (331.00) | 290.00–390.00 (351.0) | NA | 324.00–363.00 |
| Female | 300.00–342.00 (321.00) | 304.00–365.00 (331.00) | 300.00–410.00 (351.0) | NA | 319.00–358.00 |
| Male | 70.00–97.00 (86.00) | 70.00–98.00 (88.00) | 80.00–99.00 (85.0) | 55.00–98.00 (80.0) | 79.60–94.00 |
| Female | 72.00–96.00 (87.00) | 73.00–96.00 (86.00) | 80.00–95.00 (84.0) | 60.00–94.00 (79.0) | 74.70–94.20 |
| Male | 30.00–250.00 (60.00) | NA | NA | NA | NA |
| Female | 20.00–177.00 (40.00) | NA | NA | NA | NA |
| Male | 133.00–339.00 (211.00) | 88.00–352.00 (208.00) | 120.00–443.00 (239.0) | 102.00–307.00 (201.0) | 172.00–398.00 |
| Female | 143.00–369.00 (243.00) | 89.00–408.00 (224.00) | 150.00–436.00 (247.0) | 88.00–439.00 (220.0) | 185.00–445.00 |
| Male | 2.60–6.81 (4.10) | 3.50–9.20 (5.50) | 1.90–10.10 (4.1) | 2.50–7.40 (5.3) | 4.09–11.00 |
| Female | 2.80–6.70 (4.60) | 3.40–9.30 (5.30) | 2.20–7.80 (4.2) | 3.30–9.70 (5.6) | 4.02–11.40 |
| Male | 0.92–3.00 (1.60) | 1.50–5.90 (2.70) | 0.50–5.40 (1.6) | 0.80–3.90 (2.0) | 1.78–6.90 |
| Female | 1.01–3.53 (1.98) | 1.40–5.50 (2.70) | 0.50–4.40 (1.6) | 1.30–3.80 (2.3) | 1.75–7.50 |
| Male | 0.05–0.98 (0.20) | NA | 0.00–0.05 (0.2) | 0.10–1.70 (0.5) | 0.048–0.59 |
| Female | 0.12–0.42 (0.15) | NA | 0.00–0.05 (0.2) | 0.10–1.30 (0.4) | 0.041–0.55 |
| Male | 1.03–3.13 (1.71) | 1.20–5.20 (2.20) | 1.10–4.03 (2.1) | 1.00–3.50 (2.2) | 1.34–3.91 |
| Female | 1.06–2.90 (1.89) | 1.20–4.40 (2.10) | 1.20–4.30 (2.2) | 1.30–3.80 (2.2) | 1.24–3.56 |
| Male | 0.11–0.54 (0.26) | 0.20–1.40 (0.50) | 0.05–0.80 (0.2) | 0.20–0.90 (0.5) | 0.22–0.77 |
| Female | 0.14–0.65 (0.32) | 0.20–0.90 (0.40) | 0.05–0.80 (0.2) | 0.30–0.80 (0.5) | 0.20–0.71 |
| Male | 0.03–0.22 (0.08) | NA | NA | 0.01–0.19 (0.04) | 0.00–0.097 |
| Female | 0.03–0.29 (0.08) | NA | NA | 0.00–0.20 (0.04) | 0.00–0.085 |
| Blood Donors | |||||
| Male ( | 161 | - | 1047 | - | - |
| Female ( | 133 | - | 302 | - | - |
| Urban | |||||
| Male ( | - | 316 | - | - | - |
| Female ( | - | 308 | - | - | - |
| Rural | |||||
| Male ( | - | - | - | 77 | - |
| Female ( | - | - | - | 83 | - |
| National | |||||
| Male ( | - | - | - | - | 19 393 |
| Female ( | - | - | - | - | 13 526 |
Note: Reference ranges, 2.5% – 97.5%.
MCHC, corpuscular haemoglobin concentration; MCH, haemoglobin concentration; MCV, corpuscular volume; NA, not available (median values).